FDA Approvals of 2012

10 of 39


Drug: Stendra
Generic molecule: avanafil
Company: Vivus
Approval date: April 27

The scoop: The FDA issued word in April that it had stamped its OK on Stendra (avanafil), an erectile dysfunction treatment intended to boost blood flow to the penis before sex. The drug will enter a crowded field of rival and better-known treatments in a mass market, leaving some analysts to suggest that the Mountain View, CA-based biotech ($VVUS) would be better off making a deal on it as soon as possible with a Big Pharma company.